Literature DB >> 7109794

[The axillofemoral bypass as an aortoiliac principle of reconstruction in high risk patients. Long term results from 1970-1979 (author's transl)].

W Hepp, H Weidemann.   

Abstract

A total of 95 consecutive high-risk patients (average age of 68.28 years) underwent 114 axillofemoral bypass operations for revascularization of 116 lower extremities (1970-1979); 84.48% were in stage III and IV. Four bypass variations were used: unilateral bypass (70.8%), crossing bypass (4.4%), bilateral procedure (10.6%) and axillobifemoral bypass (14.2%). In elective operations, the operative mortality was 6.3%; in emergency operations one of 3 patients died. The unilateral bypass including the 5 patients on whom the crossing bypass was used showed a cumulative 5-year patency rate of 51.60%; the bifemoral bypass had a rate of 77.14% and in cases of bilateral bypass no graft was patent after 5 years. Graft thrombosis was the most common complication (47.37%); successful revision was possible in only 53.75%. In case of bifemoral procedure, graft thrombosis occurred in only 29.41%. Therefore, the authors recommend that stricter indications be employed for surgery: an axillofemoral bypass operation should only be performed in cases in stage III and IV for limb salvage and only in a "real" high-risk patient. In addition, the axillobifemoral variation should also be preferred in all cases of bilateral occlusive disease with unilateral symptomatology.

Entities:  

Mesh:

Year:  1982        PMID: 7109794     DOI: 10.1007/BF01237459

Source DB:  PubMed          Journal:  Langenbecks Arch Chir        ISSN: 0023-8236


  14 in total

1.  Twelve year experience with axillofemoral and femorofemoral bypass operations.

Authors:  D A DeLaurentis; L E Sala; E Russell; P R McCombs
Journal:  Surg Gynecol Obstet       Date:  1978-12

2.  Fifteen year experience with subcutaneous bypass grafts for lower extremity ischemia.

Authors:  J Eugene; J Goldstone; W S Moore
Journal:  Ann Surg       Date:  1977-08       Impact factor: 12.969

3.  Is axillo-bilateral femoral graft an effective substitute for aortic-bilateral iliac/femoral graft?: an analysis of ten years experience.

Authors:  W C Johnson; F W Logerfo; R W Vollman; J D Corson; E T O'Hara; J A Mannick; D C Nabseth
Journal:  Ann Surg       Date:  1977-08       Impact factor: 12.969

4.  [Surgical reconstruction of the pelvic arterial pathway (aorta-iliac vessel segment). Possibilities of evaluation of more than 1000 operations].

Authors:  H M Becker; G Heim; S Horsch; A Jabour; W Keck; C Lante
Journal:  Munch Med Wochenschr       Date:  1973-02-23

5.  The late results of axillofemoral grafts.

Authors:  J A Mannick; L E Williams; D C Nabseth
Journal:  Surgery       Date:  1970-12       Impact factor: 3.982

6.  Late results of axillary-femoral bypass grafting.

Authors:  W S Moore; A D Hall; F W Blaisdell
Journal:  Am J Surg       Date:  1971-08       Impact factor: 2.565

7.  [The axillo-femoral bypass with the Gore-Tex prosthesis (PTFE: poly-tetra-fluoro-ethylene)].

Authors:  G Azzena; E Durante; A Santini
Journal:  Minerva Cardioangiol       Date:  1980-06       Impact factor: 1.347

8.  [Axillo-femoral bypass graft; results of treatment covering an 8 years period (author's transl)].

Authors:  W Hepp
Journal:  Zentralbl Chir       Date:  1981       Impact factor: 0.942

9.  Unilateral axillary bilateral femoral bifurcation graft: a procedure for the poor risk patient with aortoiliac disease.

Authors:  L R Sauvage; S J Wood
Journal:  Surgery       Date:  1966-09       Impact factor: 3.982

10.  Bucrylate embolization of abdominal aortic aneurysms: an adjunct to nonresective therapy.

Authors:  M L Goldman; M S Sarrafizadeh; P K Philip; A M Karmody; R P Leather; N Parikh; S R Powers
Journal:  AJR Am J Roentgenol       Date:  1980-12       Impact factor: 3.959

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.